S. 1717

Status: In committee

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Ensuring Patient Access to Critical Breakthrough Products Act of 2025

Sponsored by Todd Young (Republican-IN)

Topics

Cosponsors

5

Actions

2

Roll calls

0

Amendments

0

Related bills

0

Actions

May 12, 2025 · Library of Congress

Introduced in Senate

May 12, 2025 · Senate

Read twice and referred to the Committee on Finance.

Latest activity

July 2026

Lobbying reported · Siemens Medical Solutions USA · Jul 28

Siemens Medical Solutions USA reported 2nd Quarter (Apr 1 - June 30) lobbying for Siemens Medical Solutions USA — $990,000

BillsH.R. 1 H.R. 3838 H.R. 4121 S. 1717

Lobbying reported · National Health Council · Jul 21

National Health Council reported 2nd Quarter (Apr 1 - June 30) lobbying for National Health Council — $25,779

BillsH.R. 1 H.R. 3514 H.R. 3521 H.R. 5343 H.R. 5509 S. 1717 S. 1816 S. 2903 S. 4440

Lobbying reported · Heartflow · Jul 21

Heartflow reported 2nd Quarter (Apr 1 - June 30) lobbying for Heartflow — $100,000

BillsH.R. 5343 H.R. 6197 H.R. 9260 S. 1717

Lobbying reported · Medtronic · Jul 21

Medtronic reported 2nd Quarter (Apr 1 - June 30) lobbying for Medtronic — $1,180,000

BillsH.R. 1539 H.R. 2683 H.R. 5343 H.R. 6197 H.R. 8800 S. 1546 S. 1553 S. 1717 S. 3519 S. 3658 S. 4519 S. 4784

Lobbying reported · Edwards Lifesciences · Jul 20

Edwards Lifesciences reported 2nd Quarter (Apr 1 - June 30) lobbying for Edwards Lifesciences — $280,000

BillsH.R. 5343 S. 1717

Lobbying reported · Philips Holding USA · Jul 20

Philips Holding USA reported 1st Quarter (Jan 1 - Mar 31) lobbying for Philips Holding USA — $660,000

BillsH.R. 1 H.R. 5081 H.R. 5343 H.R. 6197 S. 1717 S. 2709

Lobbying reported · Philips Holding USA · Jul 20

Philips Holding USA reported 2nd Quarter (Apr 1 - June 30) lobbying for Philips Holding USA — $640,000

BillsH.R. 1219 H.R. 1539 H.R. 5343 H.R. 6197 H.R. 8800 S. 1717 S. 4519 S. 4784

Lobbying reported · Siemens Medical Solutions USA · Jul 20

Siemens Medical Solutions USA reported 2nd Quarter (Apr 1 - June 30) lobbying for Siemens Medical Solutions USA — $860,000

BillsH.R. 2120 H.R. 2477 H.R. 4417 H.R. 5269 H.R. 5343 H.R. 6197 H.R. 8646 H.R. 8800 H.R. 9260 H.Res. 1333 H.Res. 1398 S. 1031 S. 1168 S. 1717 S. 2761 S. 2927 S. 4784

Lobbying reported · Johnson & Johnson Services · Jul 20

Johnson & Johnson Services reported 2nd Quarter (Apr 1 - June 30) lobbying for Johnson & Johnson Services — $1,440,000

Lobbying reported · Williams And Jensen · Jul 20

Williams And Jensen reported 2nd Quarter (Apr 1 - June 30) lobbying for Novocure — $60,000

BillsH.R. 5343 S. 1717

Lobbying reported · Advanced Medical Technology Assn · Jul 20

Advanced Medical Technology Assn reported 2nd Quarter (Apr 1 - June 30) lobbying for Advanced Medical Technology Assn — $971,000

BillsH.R. 1539 H.R. 5269 H.R. 5343 H.R. 6197 S. 1717 S. 2761 S. 3315 S. 4939

Lobbying reported · Avenue Solutions · Jul 20

Avenue Solutions reported 2nd Quarter (Apr 1 - June 30) lobbying for Siemens Medical Solutions USA — $70,000

BillsH.R. 5343 H.R. 6197 S. 1717

Lobbying reported · Avenue Solutions · Jul 20

Avenue Solutions reported 2nd Quarter (Apr 1 - June 30) lobbying for Edwards Lifesciences — $50,000

BillsH.R. 5343 S. 1717

Lobbying reported · Alzheimer's Association · Jul 20

Alzheimer's Association reported 2nd Quarter (Apr 1 - June 30) lobbying for Alzheimer's Association — $1,800,000

Lobbying reported · The Mcmanus Group · Jul 20

The Mcmanus Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Zimmer Biomet — $50,000

BillsH.R. 3006 H.R. 5343 H.R. 8413 S. 1717

Lobbying reported · The Mcmanus Group · Jul 20

The Mcmanus Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Roche Diagnostics — $40,000

BillsH.R. 5269 H.R. 5343 S. 1717

Lobbying reported · The Mcmanus Group · Jul 20

The Mcmanus Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Medical Device Manufacturers Association (MDMA) — $30,000

BillsH.R. 5343 S. 1717

Lobbying reported · Ml Strategies, LLC (on Behalf Of Daikin U.S. Corporation) · Jul 20

Ml Strategies, LLC (on Behalf Of Daikin U.S. Corporation) reported 2nd Quarter (Apr 1 - June 30) lobbying for Johnson & Johnson Services — $50,000

BillsH.R. 5343 H.Res. 1301 S. 1717

Lobbying reported · Novocure · Jul 19

Novocure reported 2nd Quarter (Apr 1 - June 30) lobbying for Novocure — $160,000

BillsH.R. 5343 S. 1717

Lobbying reported · Boston Scientific · Jul 17

Boston Scientific reported 2nd Quarter (Apr 1 - June 30) lobbying for Boston Scientific — $642,000

BillsH.R. 2120 H.R. 5343 H.R. 6549 H.R. 6835 H.R. 8413 H.R. 8800 S. 1031 S. 1717 S. 4784